XML 40 R29.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCKHOLDERS’ EQUITY (Tables)
 9 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of weighted-average assumptions used to estimate the fair values of the stock options granted
     
   Renovaro Inc.
Expected term (in years)   5.0 – 6.5 
Volatility   84.33% – 108.79%
Risk free interest rate   3.12% – 4.83%
Dividend yield   0%
Schedule of stock options outstanding
                                    
   Options Outstanding  Options Exercisable
   Exercise Price Ranges  Number Outstanding  Weighted Average Remaining Contractual Life (years)  Weighted Average Exercise Price  Number Exercisable  Weighted Average Remaining Contractual Life (years)  Weighted Average Exercise Price


   $0.45–4.50    4,885,441    7.43   $1.91    3,410,589    7.10   $1.98 
   $4.51–6.50    167,634    6.73   $5.33    135,376    6.06   $5.49 
   $6.51–12.00    115,231    4.91   $7.63    111,585    4.82   $7.61 
Total        5,168,306    7.35   $2.15    3,657,550    6.99   $2.28 
Schedule of stock option activity
                                 
    Shares   Weighted Average Exercise
Price		   Average Remaining Life   Weighted Average Intrinsic
Value
                 
Outstanding at beginning of period       4,401,211     $ 4.78       7.82     $ —  
Granted       4,624,026     $ 1.97                  
Exercised       —     $ —                  
Forfeited       —     $ —                  
Expired/Canceled       (3,856,931 )   $ 4.94                  
Outstanding at end of period       5,168,306     $ 2.15       7.35     $ —  
Exercisable at end of period       3,657,550     $ 2.28       6.99     $ 3,839,725  
Schedule of common stock purchase warrants outstanding
                                    
   Warrants Outstanding  Warrants Exercisable
   Exercise Price  Number Outstanding  Weighted Average Remaining Contractual Life (years)  Weighted Average Exercise Price  Number Exercisable  Weighted Average Remaining Contractual Life (years)  Weighted Average Exercise Price

   $0.53    471,698    1.41        471,698    1.41     
   $0.65    741,274    3.25        741,274    3.25     
   $1.14    1,189,036    3.98        1,189,036    3.98     
Total         2,402,008    3.25   $0.87    2,402,008    3.25   $0.87 
Schedule of warrants outstanding
               
    Shares  Weighted Average Exercise
Price		  Weighted Average Remaining
Life
          
Outstanding at beginning of period   3,548,302   $0.73    4.80 
Granted   2,805,050   $0.65    3.25 
Exercised   (3,951,344)  $0.59    — 
Cancelled/Expired   —   $—    — 
Outstanding and exercisable at end of period   2,402,008   $0.87    3.25